Results 111 to 120 of about 4,823,949 (270)

Effect of autonomic blocking agents on the cardiovascular effects of octapressin in the rat [PDF]

, 1967
Wybren de Jong, Stuart McLeod
openalex   +1 more source

Optimal blood pressure control with fewer antihypertensive medications: Achieved mostly in low‐risk hypertensive patients

The Journal of Clinical Hypertension
Recent studies indicate that intensive blood pressure (BP) targets can be reached with less than two medications. This cross‐sectional study, involving 4991 individuals from the Majiapu community, assessed the correlation between BP control and the ...
Zhanyang Zhou, Huanhuan Miao, Shijie Yang, Zheng Yin, Yingjun Chen, Yuqing Zhang   +5 more
doaj   +1 more source

The thermodynamics of metabolism, cardiovascular performance and exercise, in health and diabetes: The objective of clinical markers [PDF]

, 2013
Extensive experience in UK National Health Service metabolic syndrome/type 2 diabetes clinics highlights the need for convenient clinical marker(s) which can be readily used to indicate the success or otherwise of alternative therapies.
Atherton, MA, Collins, MW, González-Alonso, J, König, CS, Ramachandran, S   +4 more
core  

The effect of sympatholytic agents on the cardiovascular responses produced by the injection of acetylstrophanthidin into the cerebral ventricles [PDF]

, 1969
J.L. Stickney, Benedict R. Lucchesi
openalex   +1 more source

Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]

, 2010
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui, De Backer, Tine, De Buyzere, Marc, Van Bortel, Lucas, Vander Stichele, Robert   +4 more
core   +1 more source

City-wide Analysis of Electronic Health Records Reveals Gender and Age Biases in the Administration of Known Drug-Drug Interactions

, 2020
The occurrence of drug-drug-interactions (DDI) from multiple drug dispensations is a serious problem, both for individuals and health-care systems, since patients with complications due to DDI are likely to reenter the system at a costlier level.
Correia, Rion Brattig, de Araújo, Luciana P., Mattos, Mauro M., Rocha, Luis M.   +3 more
core   +1 more source

The immediate cardiovascular effects of Althesin (Glaxo CT 1341), a steroid induction agent, and thiopentone in man [PDF]

, 1972
A.J. COLEMAN, J. W. Downing, W P Leary, D G Moyes, M. Styles   +4 more
openalex   +1 more source

Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components

Chinese Medicine, 2011
This article reviews the anti-inflammatory relative and anti-infectious effects of Evodia rutaecarpa and its major bioactive components and the involvement of the nitric oxide synthases, cyclooxygenase, NADPH oxidase, nuclear factor kappa B, hypoxia ...
Wang Guei-Jane, Shen Yuh-Chiang, Chiou Wen-Fei, Liao Jyh-Fei, Chen Chieh-Fu   +4 more
doaj   +1 more source

RESPONSES OF THE CARDIOVASCULAR SYSTEM OF THE RAT TO NORADRENALINE INFUSIONS AND THEIR MODIFICATION BY ADRENOCEPTOR BLOCKING AGENTS [PDF]

, 1977
F. J. Imms, R Neame, David Powis
openalex   +1 more source

Cardiovascular Agents: Renin Inhibitors and Factor Xa Inhibitors

, 2007
Cardiovascular disease is a serious global health problem and the world's leading cause of death, with an estimated 17 million people dying from it each year.
Aparna Kasani, R. Subedi, M. Stier, D. D. Holsworth, S. Maiti   +4 more
semanticscholar   +1 more source